XML 33 R25.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

12 Months Ended

Dec. 31, 2019

Note 16. Commitments and Contingencies

Future non-cancelable minimum lease payments as of December 31, 2019 are as follows (in thousands):


Year Ended	Operating Leases		Finance Leases
2020	$	10,198	$	728
2021		6,015		2,495
2022		3,008		2,746
2023		1,594		2,754
2024		442		2,750
Thereafter		962		32,522
Total minimum lease payments	$	22,219	$	43,995

Future non-cancelable minimum lease payments as of December 31, 2018, prior to the adoption of ASC 842, were as follows (in thousands):


Year Ended	Operating Leases		Capital Leases		Financing Lease¹
2019	$	12,909	$	688	$	—
2020		8,589		472		—
2021		3,899		—		466
2022		2,011		—		2,793
2023		1,155		—		2,793
Thereafter		—		—		35,850
Total minimum lease payments	$	28,563	$	1,160	$	41,902

^1. Represents the future minimum lease payments related to a lease where we were deemed, for accounting purposes, to be the owner of the building.

We have entered into and may in the future seek to license additional rights relating to technologies or drug development candidates in connection with our drug discovery and development programs. Under these licenses, we may be required to pay upfront fees, milestone payments, and royalties on sales of future products.

In December 2018, we received a civil investigative demand from the U.S. Department of Justice (“DOJ”) for documents and information relating to our speaker programs and patient assistance programs, including our support of non-profit organizations that provide financial assistance to eligible patients. We have cooperated with this inquiry. In November 2019, the qui tam complaint underlying the DOJ inquiry was unsealed (“Complaint”), at which time we learned that a former employee whom we had terminated had made certain allegations relating to the programs described above. We then became aware that the DOJ had not intervened in the qui tam action, and, to our knowledge, the DOJ has not intervened to date. We filed an answer to the Complaint on January 22, 2020, and the action is proceeding. We cannot predict the outcome or the timing of the ultimate resolution of the investigation or qui tam action, or reasonably estimate the possible range of loss, if any, that may result from these matters. Accordingly, no reserve has been made with respect to these matters in the 2019 financial statements.

In October 2019, we entered into an agreement with Wilmington Friends School Inc., to purchase property for $50.0 million to expand our global headquarters. Under that agreement, closing of the purchase is subject to certain standard closing conditions, including an initial diligence period and a subsequent approval period.